Anne Carol Goldberg

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women
    Anne C Goldberg
    Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Cardiol 94:121-4. 2004
  2. ncbi Clinical implications of statin event trials
    Anne Carol Goldberg
    Lipid Research Center, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8046, St Louis, MO 63110, USA
    Curr Atheroscler Rep 4:337-42. 2002
  3. ncbi Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial
    Anne C Goldberg
    Lipid Research Clinic, Washington University, St Louis, MO 63110 1093, USA
    Mayo Clin Proc 79:620-9. 2004
  4. ncbi Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia
    Anne C Goldberg
    Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA
    Am J Cardiol 103:515-22. 2009

Detail Information

Publications4

  1. ncbi A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women
    Anne C Goldberg
    Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Cardiol 94:121-4. 2004
    ..This meta-analysis confirms that women respond as well as men, and possibly slightly better, to treatment with extended-release niacin and that it is a safe and effective treatment option for women with dyslipidemia...
  2. ncbi Clinical implications of statin event trials
    Anne Carol Goldberg
    Lipid Research Center, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8046, St Louis, MO 63110, USA
    Curr Atheroscler Rep 4:337-42. 2002
    ..Long-term trials of other statins are in progress or pending. The question of how much low-density lipoprotein cholesterol should be lowered may be answered by studies currently in progress...
  3. ncbi Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial
    Anne C Goldberg
    Lipid Research Clinic, Washington University, St Louis, MO 63110 1093, USA
    Mayo Clin Proc 79:620-9. 2004
    ..To compare the efficacy and safety of 10 mg of ezetimibe coadministered with simvastatin with the safety and efficacy of simvastatin monotherapy for patients with hypercholesterolemia...
  4. ncbi Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia
    Anne C Goldberg
    Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA
    Am J Cardiol 103:515-22. 2009
    ..In conclusion, ABT-335 + atorvastatin combination therapy resulted in more effective control of multiple lipid parameters than either monotherapy and may be an appropriate therapy for patients with mixed dyslipidemia...